2024-07-24 15:22:07 ET
Cellectar Biosciences, Inc. (CLRB)
KOL and Analyst Day Call
July 24, 2024, 08:00 AM ET
Company Participants
James Caruso - President and Chief Executive Officer
Sikander Ailawadhi - Professor of Medicine at Mayo Clinic
Michael Morris - Co-Founder of United Theranostics and the Medical Director of Advanced Molecular Imaging and Therapy and United Theranostic Centers of Excellence
Jarrod Longcor - Chief Operating Officer
Conference Call Participants
Edward Tenthoff - Piper Sandler
Jeff Jones - Oppenheimer
Presentation
Operator
Good morning, and welcome to Cellectar Biosciences' CLOVER WaM pivotal study data call. Today's call is being recorded.
Before we begin, I would like to remind everyone that statements made during this call relating to Cellectar's expected future performance, future business prospects or future events or plans are forward-looking statements, as defined under the Private Securities Litigation Reform Act of 1995. Although the company believes that the expectations reflected in such forward-looking statements are based upon reasonable assumptions, actual outcomes and results are subject to risk and uncertainties that could differ materially from those forecast due to the impact of many factors beyond the control of Cellectar.
The company assumes no obligation to update or supplement any forward-looking statements, whether because of new information, future events or otherwise. Participants are directed to the cautionary notes set forth in today's press release, which is available on the Investor Relations portion of the company's website, as well as the risk factors set forth in Cellectar's annual reports filed with the SEC for factors that could cause actual results to differ materially from those anticipated in the forward-looking statements.
Note that this conference call has been pre-recorded, and as a result, there will not be a question-and-answer segment.
Now, I would like to turn the call over to Jim Caruso, President and Chief Executive Officer of Cellectar. Please go ahead, sir.
James Caruso
Thank you, Operator. And as a reminder to the group, there will be a question-and-answer segment available post this call. And good morning to everyone....
Read the full article on Seeking Alpha
For further details see:
Cellectar Biosciences, Inc. (CLRB) KOL and Analyst Day Call Transcript